Advertisement
ATR vs QLV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATR is a Hold and QLV is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATR’s FA Score shows that 1 FA rating(s) are green while.
- ATR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATR’s TA Score shows that 4 TA indicator(s) are bullish.
- ATR’s TA Score: 4 bullish, 5 bearish.
Price Growth
ATR (@Pharmaceuticals: Other) experienced а +2.04% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.08%. For the same industry, the average monthly price growth was +10.50%, and the average quarterly price growth was +5.94%.
Reported Earning Dates
ATR is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-0.08% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ATR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 90 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 91 | |
SMR RATING 1..100 | 60 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 48 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ATR | QLV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 38% | 3 days ago 56% |
| Stochastic ODDS (%) | 3 days ago 59% | 3 days ago 55% |
| Momentum ODDS (%) | 3 days ago 58% | 3 days ago 78% |
| MACD ODDS (%) | 3 days ago 53% | 3 days ago 60% |
| TrendWeek ODDS (%) | 3 days ago 54% | 3 days ago 81% |
| TrendMonth ODDS (%) | 3 days ago 54% | 3 days ago 80% |
| Advances ODDS (%) | 3 days ago 55% | 5 days ago 80% |
| Declines ODDS (%) | 6 days ago 50% | 25 days ago 63% |
| BollingerBands ODDS (%) | 3 days ago 54% | 3 days ago 64% |
| Aroon ODDS (%) | 3 days ago 51% | 3 days ago 77% |
Advertisement
ATR and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.
QLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, QLV has been loosely correlated with ATR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if QLV jumps, then ATR could also see price increases.